Article may be outdated

This article is 12 days old. Some details may have changed since publication.

European AIDS Treatment Group·3 min read·medium

TheBodyPro: Hefty new study takes on weight conundrum in HIV care - and its answers are complicated

H
https://www.facebook.com/EuropeanAIDSTreatmentGroup
TheBodyPro: Hefty new study takes on weight conundrum in HIV care - and its answers are complicated
AI Summary

A new retrospective study of over 32,000 patients indicates that certain integrase inhibitors used in HIV treatment are linked to increased body weight. The findings highlight complex variations in outcomes, particularly noting specific impacts on Black women.

The latest major study exploring the role of antiretrovirals in weight gain has arrived — and its findings don’t fit neatly into either side of the debate. A new, massive analysis out of the U.S. appears to affirm that, on balance, some integrase inhibitors do have a larger impact on body weight than other drugs. But the devil is very much in the details — and those details include an important signal regarding Black women in particular, as well as some important takeaways for how we can best broach this subject with all of our patients living with HIV.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in